Menu
Not yet recruiting NCT07023575

Study on Screening Strategies for Interstitial Lung Abnormalities and Airway Lesions

Observational Interstitial Lung Abnormalities

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Interstitial Lung Abnormalities. Basic parameters: from 40 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this observational study is to learn about the comorbidity patterns of interstitial and airway abnormalities in adults undergoing health examinations in China. The main questions it aims to answer are: How do early interstitial lung abnormalities progress to comorbid interstitial and airway diseases? What are the key factors associated with this progression? Participants undergoing routine health examinations will be assessed for interstitial and airway abnormalities based on imaging and clinical data. Longitudinal follow-up will be used to evaluate disease progression and identify associated risk factors.

Primary outcome measures

  • high-resolution computed tomography (HRCT) examinations [Time frame: through study completion, an average of 1 year]

Eligibility criteria

Inclusion criteria

  • Underwent chest CT examination between January 1, 2017 and December 31, 2024
  • Age 18 years or older at the time of examination

Exclusion criteria

\- Missing or incomplete key demographic or imaging information (e.g., missing date of examination, sex, age, or CT report)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 10 centers
  • China-Japan Friendship Hospital — Beijing
  • Zhongshan Hospital, Fudan University — Shanghai
  • Zhongguancun Meinian Health Industry Research Institute — Beijing
  • Central South University — Changsha
  • Affiliated Hospital of Guizhou Medical University — Guiyang
  • Zhejiang University — Hangzhou
  • Henan Provincial People's Hospital — Henan
  • The Affiliated Hospital of Qingdao University — Qingdao
  • … and 2 more centers

Identifiers

NCT: NCT07023575 · 2024ZD0522301

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗